Epic Sciences Raises $52M to Expand Cancer Diagnostic Portfolio | Enterpreneurship
Want create site? Find Free WordPress Themes and plugins.
Oncology diagnostics company Epic Sciences, which last year launched what it describes as the only test that can help guide treatment for patients with advanced prostate cancer, has raised $52 million in a financing led by New York private equity firm Blue Ox Healthcare Partners to develop tests to address more types of cancer.
The San Diego-based company, which announced the close of the Series E round Wednesday, said it will use the proceeds to create additional blood tests, often referred to as liquid biopsies, to help guide clinicians in selecting the best course of treatment for patients who have been… Read more »
Reprints | Share: 
UNDERWRITERS AND PARTNERS
Did you find apk for android? You can find new Free Android Games and apps.